Pubblicazioni Scientifiche
Dermatologia24 ott 2022
The impact of merkel cell polyomavirus
There are numerous findings over the past decade have indicated that Merkel cell carcinoma (MCC) may have two pathways of pathogenesis
24 ott 2022
The effects of systemic immunomodulatory treatments on COVID-19
Limited data are available on the effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis (AD).
17 ott 2022
Brunsting-Perry pemphigoid
Brunsting-Perry pemphigoid (BPP) is a rare, autoimmune bullous skin disorder classified within the spectrum of mucous membrane pemphigoid (MMP).
17 ott 2022
Clinical, dermoscopic and histopathological findings in localized human monkeypox
Clinical, dermoscopic and histopathological findings in localized human monkeypox: a case from northern Italy
17 ott 2022
Leukonychia
Changes in nail color can provide important clues of underlying systemic and skin disease
10 ott 2022
Alpha-1 antitrypsin deficiency
Panniculitis represents a rare and potentially lethal manifestation of alpha-1 antitrypsin deficienc
10 ott 2022
Surgical excision margins for fibrohistiocytic tumors
Mohs micrographic surgery or wide local excision is the treatment of choice for fibrohistiocytic tumors with metastatic potential
10 ott 2022
Dermoscopy of skin parasitoses
Besides classic applications, dermoscopy has gained significant appreciation also for non-tumoral dermatoses
03 ott 2022
Treatment of Nail Psoriasis
Nail psoriasis has a considerable negative impact on the quality of life by limiting the patient’s household chores
03 ott 2022
Dupilumab in children aged 6 months to younger than 6 years
Background Current systemic treatments for children younger than 6 years with moderate-to-severe atopic dermatitis
03 ott 2022
FDA approves Ruxolitinib
The Food and Drug Administration (FDA) has authorized Ruxolitinib (Opzelura)
28 set 2022
The role of HPV in keratinocyte skin cancer development
Keratinocyte skin cancers are the most frequent malignancy, accounting for approximately 30% of all cancers
28 set 2022
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas
Brentuximab vedotin (BV) has been approved for CD30-expressing cutaneous T-cell lymphoma
28 set 2022
Atopic dermatitis and risk of major neuropsychiatric disorders in children
Paediatric atopic dermatitis (AD) has been linked to neuropsychiatric comorbidities
19 set 2022
Eczema European guideline part II
The evidence- and consensus-based guideline on atopic eczema
19 set 2022
Eczema European guideline part I
The evidence-and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline
19 set 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities
Cutaneous immune-related adverse events (irAEs) represent the most frequent toxicities
15 set 2022
Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus
Dupilumab has demonstrated a great reduction in chronic pruritus that is the hallmark of atopic dermatitis
15 set 2022
Assessing changes in facial skin quality using
Studies utilizing reflectance confocal microscopy (RCM) and dynamic optical coherence tomography
15 set 2022
Dermoscopy of cutaneous adnexal tumours a systematic review
Cutaneous adnexal tumours (ATs) encompass a variegated group of hamartomas and benign or malignant tumours